Literature DB >> 12535811

Spironolactone in chronic heart failure:all's well that ends well.

W H Wilson Tang, Gary S Francis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535811     DOI: 10.1016/s0735-1097(02)02695-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Use and side-effect profile of spironolactone in a private cardiologist's practice.

Authors:  Eric M Williams; Richard E Katholi; Marcey R Karambelas
Journal:  Clin Cardiol       Date:  2006-04       Impact factor: 2.882

Review 2.  A landmark for popperian epidemiology: refutation of the randomised Aldactone evaluation study.

Authors:  Elard Koch; Alvaro Otarola; Aida Kirschbaum
Journal:  J Epidemiol Community Health       Date:  2005-11       Impact factor: 3.710

Review 3.  Eplerenone : a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.